top of page

Insights

Insights

Insights on First-in-Class Market Sizing

This paper lays out FSI's funnel for sizing the reachable population behind a first-in-class asset, the diagnostic and payer readiness gaps that delay adoption, and five questions to answer before a Phase 3 commitment.

Highlights Q2 2026

Agentic AI for Pharma Commercialization Go-to-Market Strategy Medical Device Competitive Positioning & Board Advisory AI-Enabled Cardiac Device Market Entry Strategy Emerging Cardiovascular Device Commercial & Fundraising Assessment Academic Medical Center Digital Health Investment Strategy Chronic Hypoparathyroidism Patient Journey & Launch Strategy Prostate Cancer Diagnostics US Partnering & Commercialization Strategy

Highlights Q1 2026

AI-Enabled Cardiac Device Market Entry Strategy Medical Device Coating Services Market Expansion Agentic AI for Pharma Commercialization Robotic Surgery Tool Go-to-Market Strategy Female Oncology Market Assessment Kidney Stone Management Device Market Assessment AI-Powered Patient Management Platform Pricing Strategy Academic Medical Center Digital Health Innovation Program Optimization

Digital Health Market Intelligence Spring 2026

The report analyzes revenue growth and investment trends across key Digital Health segments and stakeholders (including Payers, Big Four Tech and Diversified Medtech Companies). The Spotlight explores how LLMs are reshaping care delivery.

Highlights Q3 2025

Urinary Incontinence Device Concepts Market Assessment AI-Enabled Clinical Workflow Tools AMC Research Operations and Grants Management Optimization Bioprocessing Services Strategy Roadmap Skin Substitute Reimbursement Strategy Assessment Medical Device Contract Manufacturing Growth Strategy

Winning in Neuro

Why capital is flowing to neuroscience companies that can show commercial differentiation on top of positive clinical data.

Spotlight on Neuroimaging Summer 2026

Highlighting commercial opportunities across FSI's Measure–Modulate–Remodel framework

Robotic Assisted Surgery Highlights Q1 2026

This report covers key events and emerging trends in the Robotic Assisted Surgery (RAS) market through Q1 2026. It includes a key events snapshot across leading platforms, a strategic deep dive into J&J's multi-platform RAS portfolio, and an overview of endoluminal robotics. Additionally, it covers the accelerating shift to ASCs, AI as a competitive differentiator, and shifting international dynamics across Asia-Pacific and Europe.

Highlights Q4 2025

Bioprocessing Innovation Roadmap and Opportunity Prioritization Urology Device Asia Market Landscape and Positioning Strategy AI-Enabled Clinical Workflow Tool Fundraising Support AI-Enabled Cardiac Device Market Entry Strategy Academic Health System Innovation Fund Portfolio Review Novel Prostate Cancer Screening Test Go-to-Market Strategy Endocrine Therapy Adverse Event Market Impact Study Medical Supplies Due Diligence

Digital Health Market Intelligence Fall 2025

The report analyzes revenue growth and investment trends across key Digital Health segments and stakeholders (including Payers, Big Four Tech and MedTech). The spotlight is a deeper dive into AI Adoption in Healthcare.

News

News
News (new).png

Join our email list to be informed of FSI insights

Thanks for submitting!

Fletcher Spaght, Inc.

75 State Street, Suite 100
Boston, MA 02109

FSI Logo

  • LinkedIn
  • Twitter
  • YouTube

© 2026 by Fletcher Spaght Inc.. Proudly created by Anchor Watch Marketing

bottom of page